Leishmaniasis, Cutaneous: Clinical Trials

113 trials for Leishmaniasis, Cutaneous, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

70 completed, 13 unknown, 10 recruiting, 10 terminated. 46 Phase 2, 28 Phase 3, 11 Not applicable, 11 Phase 1, 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 246Completed 30, Unknown 6, Terminated 5, Recruiting 4, Withdrawn 1
Phase 328Completed 15, Unknown 6, Terminated 4, Not yet recruiting 2, Recruiting 1
Not applicable11Completed 8, Not yet recruiting 2, Recruiting 1
Phase 111Completed 8, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Phase 44Completed 4
Early Phase 11Completed 1

Follow Leishmaniasis, Cutaneous: new trials by email Literature Review of Leishmaniasis, Cutaneous trials Research Report on Leishmaniasis, Cutaneous

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)
Sodium Stibogluconate (SSG), Miltefosine, Miltefosine + Paromomycin - Cutaneous Leihmaniasis
Phase 3Not yet recruitingInstitute of Tropical Medicine, Belgium9002027-01-012026-03-10
Immersive Technology Headsets to Reduce Procedural Pain and Anxiety: Feasibility and Effects in Cutaneous Leishmaniasis Patients in Pakistan
Virtual Reality - Cutaneous Leishmaniasis, Pain
Not applicableNot yet recruitingStanford University152027-01-012026-10-05
Ex Vivo Immunogenicity Screening of Vaccine Candidate Antigen Combinations in Ethiopian Patients With Leishmaniasis
Leishmaniasis, Cutaneous, Leishmaniasis
RecruitingInstitute of Tropical Medicine, Belgium902026-05-262026-08-24
Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers
A mobile app with AI functionality for diagnosing skin-related NTDs - Skin and Connective Tissue Diseases, Neglected Tropical Diseases
Not applicableNot yet recruitingKenya Medical Research Institute24202026-05-012026-04-02
Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II.
Arnica Tincture, Meglumine antimoniate. - Leishmaniasis, Cutaneous
Phase 3RecruitingUniversidad de Antioquia962026-03-112026-04-02
Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis
MILTEFOSINE gel - Cutaneous Leishmaniasis, Cutaneous Leishmaniasis, American
Phase 1Not yet recruitingUniversidad Industrial de Santander152026-01-012025-09-08
Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care Setup
Thermotherapy - Cutaneous Leishmaniasis
Not applicableRecruitingArmauer Hansen Research Institute, Ethiopia1032025-04-242026-10-16
Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in Ethiopia
Fusidic Acid, Vehicle cream - Leishmaniasis, Cutaneous
Phase 3Not yet recruitingInstitute of Tropical Medicine, Belgium1802025-04-012024-11-19
Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis
Metronidazole - Cutaneous Leishmaniasis
Phase 2RecruitingHayder Adnan Fawzi402025-02-102025-02-14
Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis
Levofloxacin 0.5% - Cutaneous Leishmaniasis
Phase 2RecruitingHayder Adnan Fawzi402025-02-092025-09-30
Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate
Ciprofloxacin (BAYO9867), sodium stibogluconate (Pentostam) - Cutaneous Leishmaniasis
Phase 2RecruitingAl-Mustafa University College802025-02-072025-09-30
Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis With Inhaled Pentamidine Plus Oral Miltefosine
Miltefosine Oral Capsule - Mucosal Leishmaniasis
Phase 2RecruitingFundacion Nacional de Dermatologia302025-02-042025-02-26
LEISH-PED: Study on Leishmaniasis in Children
Leishmania Infantum Disease, Leishmaniasis, Visceral
RecruitingMeyer Children's Hospital IRCCS2002025-01-302026-04-01
OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients
Miltefosine - Cutaneous Leishmaniases
RecruitingInstitute of Tropical Medicine, Belgium802024-06-182024-07-23
Tofacitinib Associated With Meglumine Antimoniate in Cutaneous Leishmaniasis
Oral tofacitinib, Parenteral meglumine antimoniate - Cutaneous Leishmaniasis, American
Phase 2 / Phase 3UnknownHospital Universitário Professor Edgard Santos222023-10-012023-08-25
Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis
Arnica Tincture - Leishmaniasis, Cutaneous
Phase 1Active not recruitingUniversidad de Antioquia162023-05-032025-02-10
Epidemiology of Cutaneous Leishmaniasis in Niger, Mali, Togo : Mapping of Clinical Cases, Species, Reservoirs and Vectors of the Disease
Clinical and epidemiological data, Parasitological samples, Assessment of clinical course and response to treatment - Cutaneous Leishmaniasis
CompletedCentre Hospitalier de Cayenne2702023-04-012024-11-20
Randomised Clinical Trial in Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan
drug: miltefosine with thermotherapy - Old World Cutaneous Leishmaniasis
Phase 3CompletedMedecins Sans Frontieres, Netherlands6452022-10-072026-07-30
Study of Cases of Cutaneous Leishmaniasis Treated With Miltefosine in French Guiana, Retrospective Study
Data collection, Questionnaires - Cutaneous Leishmaniases, Treatment Adherence
UnknownCentre Hospitalier de Cayenne202022-08-082022-08-09
Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly
Miltefosine 50mg, Pentoxifylline 400mg, Liposomal Amphotericin B - Leishmaniasis; Brazilian, Leishmaniasis, Mucocutaneous
Phase 2 / Phase 3UnknownUniversity of Brasilia1002022-06-222023-09-15

Showing 20 of 113. Sign in to see all of them.

Narrower conditions

Leishmaniasis (35)  ·  Leishmaniasis, Mucocutaneous (21)  ·  Hyperthermia (5)  ·  Leishmaniasis, Visceral (4)  ·  Neglected Diseases (3)  ·  Insect Bites and Stings (2)  ·  Parasitic Diseases (2)  ·  Skin Diseases, Parasitic (2)  ·  Vector Borne Diseases (2)  ·  Anxiety Disorders (1)  ·  Buruli Ulcer (1)  ·  Cicatrix (1)  ·  Disease (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)

Broader conditions

Euglenozoa Infections (113)  ·  Infections (113)  ·  Protozoan Infections (113)  ·  Skin Diseases (113)  ·  Skin Diseases, Infectious (113)  ·  Skin and Connective Tissue Diseases (112)  ·  Parasitic Diseases (111)  ·  Skin Diseases, Parasitic (111)  ·  Vector Borne Diseases (111)  ·  Leishmaniasis (78)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Wounds and Injuries (7)  ·  Signs and Symptoms (6)  ·  Body Temperature Changes (5)

Interventions

miltefosine (24)  ·  Meglumine Antimoniate (21)  ·  Paromomycin (9)  ·  Antimony Sodium Gluconate (8)  ·  Hyperthermia, Induced (3)  ·  Pentamidine (3)  ·  Pentoxifylline (3)  ·  liposomal amphotericin B (3)  ·  Allopurinol (2)  ·  Antimony (2)  ·  Arnicae flos extract (2)  ·  Cryotherapy (2)  ·  Data Collection (2)  ·  Imiquimod (2)  ·  Solutions (2)

Sponsors

U.S. Army Medical Research and Development Command (12)  ·  Hospital Universitário Professor Edgard Santos (9)  ·  Institute of Tropical Medicine, Belgium (9)  ·  Access to Advanced Health Institute (AAHI) (5)  ·  Centro Internacional de Entrenamiento e Investigaciones Médicas (5)  ·  Drugs for Neglected Diseases (5)  ·  Fundacion Nacional de Dermatologia (5)  ·  Universidad de Antioquia (4)  ·  University of York (4)  ·  Centre Hospitalier de Cayenne (3)  ·  Knight Therapeutics (USA) Inc (3)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  Tehran University of Medical Sciences (3)  ·  University of Brasilia (3)  ·  Foundation Fader (2)

Countries

Brazil (19)  ·  Colombia (14)  ·  Bolivia (12)  ·  Ethiopia (10)  ·  United States (9)  ·  Peru (7)  ·  Tunisia (5)  ·  Pakistan (4)  ·  France (3)  ·  Iran (3)  ·  Iraq (3)  ·  Israel (3)  ·  Panama (3)  ·  United Kingdom (3)  ·  Mali (2)

Top investigators

Afif Ben Salah, M.D., Ph.D. (3)  ·  Jaime Soto, MD (3)  ·  Paulo RL Machado, MD, PhD (3)  ·  Alejandro Llanos-Cuentas, MD, PhD (2)  ·  Armando O. Schubach, MD, PhD (2)  ·  Charles Lacey, BMBS, MD (2)  ·  Edgar M Carvalho, MD, PhD (2)  ·  Franco M Piazza, MD, MPH (2)  ·  Ivan Dario Velez, Prof (2)  ·  Johan van Griensven, MD,PhD (2)  ·  Nancy C Saravia, PhD (2)  ·  Wim Adriaensen, PhD (2)

Results publications

PMID 28379954, PMID 23877689, PMID 34053461, PMID 11353640, PMID 19415122, PMID 19636365, PMID 20016847, PMID 20231896, PMID 20438389, PMID 20851080, PMID 21200420, PMID 21460008, PMID 22238470, PMID 22594858, PMID 23388004, PMID 23390069, PMID 23740007, PMID 27803094, PMID 27927991, PMID 27956421, PMID 28558061, PMID 29898753, PMID 29988004, PMID 30044792, PMID 30260376, PMID 30379814, PMID 30815688, PMID 32894278, PMID 33253864, PMID 33781913, PMID 33909619, PMID 34048461, PMID 34693027, PMID 35041672, PMID 35255096, PMID 36395328, PMID 36913433, PMID 37252616, PMID 37624352, PMID 39095597, PMID 39147194, PMID 39253357, PMID 40611204, PMID 40825042

NIH funding

2016 (1), 2018 (1)